Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib

Por Patrick Harrington, Katie J. Doores, Jamie Saunders, Marc de Lord, Chandan Saha, Thomas Lechmere, Hataf Khan, Ho Pui Jeff Lam, Amy O’ Reilly, Claire Woodley, Susan Asirvatham, Richard Dillon, Natalia Curto-Garcia, Jennifer O’ Sullivan, Shahram Kordasti, Kavita Raj, Michael H. Malim, Deepti Radia, Donal McLornan, Claire Harrison, Hugues de Lavallade
Publicado em 2022-04-01